Award recordCONTRACT

JUBILANT DRAXIMAGE RADIOPHARMACIES, INC.

PIID 36C24120P0077· VHA· 241-NETWORK CONTRACT OFFICE 01 (36C241)· 6505 · DRUGS AND BIOLOGICALS· FY2020· $383,892 net obligations· UEI EQ4VSLH8RC33· FL

Description

RADIOPHARMACEUTICALS OY2

Base award description: RADIOPHARMACEUTICALS

First action · last action
2019-10-21 · 2026-04-28
Transactions
13
First transaction's obligation
$69,253
Base + all options value (sum of deltas)
$470,647
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
3
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 13 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$391,563$0Base award · 2019-10-21 · this action $69,253 · running total $69,253Modification P00001 · 2019-12-30 · this action $11,822 · running total $81,075Modification P00003 · 2020-10-31 · this action $72,431 · running total $153,506Modification P00004 · 2021-08-03 · this action -$24,993 · running total $128,513Modification P00005 · 2021-10-28 · this action $91,065 · running total $219,578Modification P00007 · 2022-10-31 · this action $92,163 · running total $311,741Modification P00006 · 2023-07-28 · this action -$43,535 · running total $268,206Modification P00008 · 2023-10-31 · this action $92,160 · running total $360,366Modification P00009 · 2024-10-29 · this action -$18,803 · running total $341,563Modification P00010 · 2024-11-13 · this action $50,000 · running total $391,563Modification P00011 · 2025-10-20 · this action -$26,538 · running total $365,025Modification P00012 · 2025-12-05 · this action $19,000 · running total $384,025Modification P00013 · 2026-04-28 · this action -$133 · running total $383,892
  • Base2019-10-21+$69,253= $69,253
  • Mod P000012019-12-30+$11,822= $81,075
  • Mod P000032020-10-31+$72,431= $153,506
  • Mod P000042021-08-03-$24,993= $128,513
  • Mod P000052021-10-28+$91,065= $219,578
  • Mod P000072022-10-31+$92,163= $311,741
  • Mod P000062023-07-28-$43,535= $268,206
  • Mod P000082023-10-31+$92,160= $360,366
  • Mod P000092024-10-29-$18,803= $341,563
  • Mod P000102024-11-13+$50,000= $391,563
  • Mod P000112025-10-20-$26,538= $365,025
  • Mod P000122025-12-05+$19,000= $384,025
  • Mod P000132026-04-28-$133= $383,892
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2019-10-21+$69,253$69,253RADIOPHARMACEUTICALS
Mod P00001· FUNDING ONLY ACTION2019-12-30+$11,822$81,075RADIOPHARMACEUTICALS
Mod P00003· EXERCISE AN OPTION2020-10-31+$72,431$153,506RADIOPHARMACEUTICALS
Mod P00004· OTHER ADMINISTRATIVE ACTION2021-08-03−$24,993$128,513DECREASE ($24,992.88) 650C08057
Mod P00005· EXERCISE AN OPTION2021-10-28+$91,065$219,578RADIOPHARMACEUTICALS OY2
Mod P00007· EXERCISE AN OPTION2022-10-31+$92,163$311,741RADIOPHARMACEUTICALS OY2
Mod P00006· OTHER ADMINISTRATIVE ACTION2023-07-28−$43,535$268,206RADIOPHARMACEUTICALS OY2
Mod P00008· EXERCISE AN OPTION2023-10-31+$92,160$360,366RADIOPHARMACEUTICALS OY2
Mod P00009· FUNDING ONLY ACTION2024-10-29−$18,803$341,563RADIOPHARMACEUTICALS OY2
Mod P00010· EXERCISE AN OPTION2024-11-13+$50,000$391,563RADIOPHARMACEUTICALS OY2
Mod P00011· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2025-10-20−$26,538$365,025RADIOPHARMACEUTICALS OY2
Mod P00012· FUNDING ONLY ACTION2025-12-05+$19,000$384,025RADIOPHARMACEUTICALS OY2
Mod P00013· OTHER ADMINISTRATIVE ACTION2026-04-28−$133$383,892RADIOPHARMACEUTICALS OY2

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI EQ4VSLH8RC33)

AwardOffice · PSC / listingNet obligationsFY
36C24826N0411248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$231,773FY2026
36C24126N0274241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS$771,411FY2026
36C25226N0210252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$164,999FY2026
36C26126N0065261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$153,991FY2026
36C24825N0208248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$224,563FY2025
36C24125N0495241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS$656,883FY2025

Other recipients under 6505 from 241-NETWORK CONTRACT OFFICE 01 (36C241) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24126P0328CARDINAL HEALTH 414, LLC241-NETWORK CONTRACT OFFICE 01 (36C241)$999,797FY2026
36C24126F0121MCKESSON CORPORATION241-NETWORK CONTRACT OFFICE 01 (36C241)$16,333FY2026
36C24126F0112VANTIVE US HEALTHCARE LLC241-NETWORK CONTRACT OFFICE 01 (36C241)$545,567FY2026
36C24126N0603AMERICAN NATIONAL RED CROSS, THE241-NETWORK CONTRACT OFFICE 01 (36C241)$1,998,719FY2026
36C24126F0109BOSTON SCIENTIFIC CORP241-NETWORK CONTRACT OFFICE 01 (36C241)$304,950FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24120P0077_3600_-NONE-_-NONE- · retrieved 2026-09-26.